logo
Twitter
Discord
Email
logo
Nature's Sunshine Products, Inc.

Nature's Sunshine Products, Inc.

NASDAQ•NATR
CEO: Mr. Terrence O. Moorehead
Sector: Consumer Defensive
Industry: Packaged Foods
Listing Date: 2009-06-25
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
Contact Information
2901 West Bluegrass Boulevard, Suite 100, Lehi, UT, 84043, United States
801-341-7900
www.naturessunshine.com
Market Cap
$421.12M
P/E (TTM)
28.1
10.8
Dividend Yield
--
52W High
$24.13
52W Low
$11.01
52W Range
100%
Rank26Top 13.0%
5.5
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q3 2025 Data

Revenue

$128.34M+11.97%
4-Quarter Trend

EPS

$0.30+30.44%
4-Quarter Trend

FCF

$16.79M+113.00%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Q3 Sales and Profit Growth Third quarter Net sales reached $128.3M, a 12.0% increase; Operating Income surged 69.9% to $9.0M.
Nine Month Net Income Jumps Nine-month Net Income attributable to common shareholders was $15.4M, reflecting an 84.8% increase over 2024.
Operating Cash Flow Doubles Net cash provided by operating activities was $25.4M for nine months, nearly doubling the $13.1M provided in 2024.
Balance Sheet Cash Position Cash and equivalents increased to $95.6M as of September 30, 2025, up from $84.7M at year-end 2024.

Risk Factors

Trade Compliance Investigation Closed Filed final voluntary self-disclosures regarding apparent trade controls violations; outcome uncertainty remains regarding potential fines.
Eastern Europe Geopolitical Risk Sustained conflict in Eastern Europe continues to impact business operations and sales in the region for the foreseeable future.
Tariff Cost Pressure Monitoring Monitoring potential material cost increases from tariffs on raw materials; full-year impact is not expected to be material.
Rising Current Liabilities Total current liabilities increased to $83.6M by September 30, 2025, driven by higher accrued liabilities and incentives.

Outlook

China JV Full Ownership Agreements finalized to purchase remaining interests in two China joint ventures for $7.0M cash consideration by year-end.
Share Repurchase Program Active Repurchased $14.4M in common stock during nine months; $19.3M remains available under the authorized program.
International Sales Reliance International operations remain a significant sales driver, though results are subject to foreign currency exchange rate fluctuations.
Tax Disclosure Standard Adoption Adoption of ASU 2023-09 regarding income tax disclosures is effective December 15, 2024, with no expected material impact.

Peer Comparison

Revenue (TTM)

B&G Foods, Inc.BGS
$1.84B
-6.0%
USANA Health Sciences, Inc.USNA
$912.67M
+5.9%
Nature's Sunshine Products, Inc.NATR
$474.54M
+6.6%

Gross Margin (Latest Quarter)

USANA Health Sciences, Inc.USNA
73.4%
-6.9pp
Nature's Sunshine Products, Inc.NATR
73.3%
+1.9pp
FitLife Brands, Inc.FTLF
37.2%
-6.6pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
NATR$421.12M28.19.5%5.4%
WILC$415.08M13.818.5%0.7%
USNA$400.90M23.63.2%0.0%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
2.8%
Moderate Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Next earnings:Mar 9, 2026
|
EPS:-
|
Revenue:-
Reports
All Years

  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 6, 2025|
    Revenue: $128.34M+12.0%
    |
    EPS: $0.30+30.4%
    Beat

  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Jul 31, 2025|
    Revenue: $114.75M+3.8%
    |
    EPS: $0.29+314.3%
    Beat

  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 6, 2025|
    Revenue: $113.25M+2.0%
    |
    EPS: $0.26+116.7%
    Beat

  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Mar 11, 2025|
    Revenue: $454.36M+2.0%
    |
    EPS: $0.41-48.1%
    Beat

  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 7, 2024|
    Revenue: $114.62M+3.1%
    |
    EPS: $0.23+53.3%
    Beat

  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 8, 2024|
    Revenue: $110.55M-5.1%
    |
    EPS: $0.07-46.2%
    Miss

  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 7, 2024|
    Revenue: $110.99M+2.2%
    |
    EPS: $0.12+82.6%
    Miss

  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Mar 12, 2024|
    Revenue: $445.32M+5.5%
    |
    EPS: $0.79+4050.0%
    Beat